INULIN - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for inulin and what is the scope of freedom to operate?
Inulin
is the generic ingredient in one branded drug marketed by Iso Tex and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for inulin.
Summary for INULIN
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 7 |
Clinical Trials: | 43 |
Patent Applications: | 6,031 |
Formulation / Manufacturing: | see details |
DailyMed Link: | INULIN at DailyMed |
Recent Clinical Trials for INULIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rutgers, The State University of New Jersey | Phase 2 |
Centre Hospitalier Universitaire de Saint Etienne | Phase 1 |
Yanqing Li | Early Phase 1 |
US Patents and Regulatory Information for INULIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Iso Tex | INULIN AND SODIUM CHLORIDE | inulin | INJECTABLE;INJECTION | 002282-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |